Cagrilintide 10mg Research Peptide

Third-Party Tested

≥98% Purity

Fast Shipping

COA Included

For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.

$150.00

Compare

Add to wishlist

Shipping and returns

Authorities in our business will tell in no uncertain terms that Lorem Ipsum is that huge, huge no no to forswear forever. Not so fast, I'd say, there are some redeeming factors in favor of greeking text, as its use is merely the symptom of a worse problem to take into consideration.

Product care

Anyway, you still use Lorem Ipsum and rightly so, as it will always have a place in the web workers toolbox, as things happen, not always the way you like it, not always in the preferred order.

Product details

Made possible by exploring innovative molded plywood techniques, Iskos-Berlin’s Soft Edge Chair blends strong curves with extreme lightness to create a three-dimensionality not usually possible with 2-D plywood.

Description

For Research Purposes Only. Not approved for human consumption.

Cagrilintide Research Peptide 10mg

Cagrilintide is a long-acting synthetic analog of human amylin — the peptide hormone co-secreted with insulin from pancreatic beta cells. It activates amylin receptors in the brain to regulate satiety, gastric emptying, and glucose homeostasis. The CagriSema combination (Cagrilintide + Semaglutide) has demonstrated up to 25% weight loss in Phase 3 research, establishing it as a critical compound for dual-mechanism metabolic studies.

Research Applications

Amylin receptor signaling research
Combination metabolic studies (amylin + GLP-1)
Satiety and appetite regulation investigations
Gastric emptying and GI motility research
Obesity biology and body weight regulation

Quality Specifications

Purity: ≥98% (HPLC verified)
Compound: Cagrilintide
Molecular Weight: ~3.9 kDa
Form: Lyophilized powder
Storage: -20°C, protect from light
COA: Batch-specific, ISO-accredited laboratory

Frequently Asked Questions

Q: Why combine Cagrilintide with GLP-1 agonists?
A: Amylin and GLP-1 receptors are in overlapping but distinct brain regions. Research suggests combining both mechanisms produces additive or synergistic satiety effects beyond either pathway alone.

Q: How does Cagrilintide differ from pramlintide?
A: Pramlintide requires multiple daily doses. Cagrilintide is engineered for once-weekly dosing in research protocols, making it practical for longitudinal study designs.

Q: What are amylin receptors?
A: Complexes of calcitonin receptors with receptor activity-modifying proteins (RAMPs), expressed in the area postrema and hypothalamus — key regions regulating appetite and energy balance.

For laboratory research use only. Not for human consumption. Not evaluated by the FDA.

Customer Reviews

Rated 0 out of 5

0 reviews

Rated 5 out of 5

Rated 4 out of 5

Rated 3 out of 5

Rated 2 out of 5

Rated 1 out of 5

Reviews

Clear filters

There are no reviews yet.

Peptides

$50.00